CA2253769C - Composes pharmaceutiques a base de fenofibrate - Google Patents
Composes pharmaceutiques a base de fenofibrate Download PDFInfo
- Publication number
- CA2253769C CA2253769C CA 2253769 CA2253769A CA2253769C CA 2253769 C CA2253769 C CA 2253769C CA 2253769 CA2253769 CA 2253769 CA 2253769 A CA2253769 A CA 2253769A CA 2253769 C CA2253769 C CA 2253769C
- Authority
- CA
- Canada
- Prior art keywords
- water
- precipitate
- fenofibrate
- soluble excipient
- solvents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2253769 CA2253769C (fr) | 1998-11-10 | 1998-11-10 | Composes pharmaceutiques a base de fenofibrate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2253769 CA2253769C (fr) | 1998-11-10 | 1998-11-10 | Composes pharmaceutiques a base de fenofibrate |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2253769C true CA2253769C (fr) | 2000-09-26 |
Family
ID=29425633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2253769 Expired - Fee Related CA2253769C (fr) | 1998-11-10 | 1998-11-10 | Composes pharmaceutiques a base de fenofibrate |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2253769C (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005034908A2 (fr) * | 2003-10-10 | 2005-04-21 | Lifecycle Pharma A/S | Forme posologique solide comprenant une fibrate et une statine |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
US7658944B2 (en) | 2003-10-10 | 2010-02-09 | Lifecycle Pharma A/S | Solid dosage form comprising a fibrate |
US7732413B2 (en) | 2003-03-07 | 2010-06-08 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7741289B2 (en) | 2003-03-07 | 2010-06-22 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US8062664B2 (en) * | 2003-11-12 | 2011-11-22 | Abbott Laboratories | Process for preparing formulations of lipid-regulating drugs |
-
1998
- 1998-11-10 CA CA 2253769 patent/CA2253769C/fr not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
US7732413B2 (en) | 2003-03-07 | 2010-06-08 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7741289B2 (en) | 2003-03-07 | 2010-06-22 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
WO2005034908A2 (fr) * | 2003-10-10 | 2005-04-21 | Lifecycle Pharma A/S | Forme posologique solide comprenant une fibrate et une statine |
WO2005034908A3 (fr) * | 2003-10-10 | 2005-08-11 | Lifecycle Pharma As | Forme posologique solide comprenant une fibrate et une statine |
US7658944B2 (en) | 2003-10-10 | 2010-02-09 | Lifecycle Pharma A/S | Solid dosage form comprising a fibrate |
US8124125B2 (en) | 2003-10-10 | 2012-02-28 | Veloxis Pharmaceuticals A/S | Solid dosage form comprising a fibrate |
US8481078B2 (en) | 2003-10-10 | 2013-07-09 | Veloxis Pharmaceuticals A/S | Solid dosage form comprising a fibrate |
US8062664B2 (en) * | 2003-11-12 | 2011-11-22 | Abbott Laboratories | Process for preparing formulations of lipid-regulating drugs |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6511681B2 (en) | Aqueous solubility pharmaceutical formulations | |
RU2351316C2 (ru) | Лекарственные формы с замедленным высвобождением зипразидона | |
EP1039909B1 (fr) | Procede de preparation et composition d'une preparation orale d'itraconazole | |
JP2002523443A (ja) | オメプラゾール製剤 | |
WO2000024423A1 (fr) | Particules a liberation prolongee | |
EP0630233A1 (fr) | Composition pour preparations buvables. | |
HU226492B1 (en) | Enteric coated pharmaceutical tablet containing didanoside | |
JP2008540644A (ja) | 新規粒質化方法及びそれから生成される粒質物 | |
WO2008077591A2 (fr) | Dispersion solide d'un antagoniste de la neurokinine | |
WO2005077342A1 (fr) | Microcomprimes de lansoprazole gastroresistants | |
SK7162001A3 (en) | Compositions comprising cefuroxime axetil | |
JP2000514057A (ja) | 増強されたバイオアベイラビリティを有する抗真菌剤の固溶体 | |
US20100204292A1 (en) | Pharmaceutical compositions comprising intra-and extra-granular fractions | |
JP2004525887A (ja) | 新規フェノフィブラート錠剤 | |
CA2253769C (fr) | Composes pharmaceutiques a base de fenofibrate | |
US20110311625A1 (en) | Solid dosage forms of fenofibrate | |
US20020028248A1 (en) | Rapid-release microdispersible ecadotril preparation | |
US20030096014A1 (en) | Solid pharmaceutical compositions for oral administration comprising itraconazole | |
US8062664B2 (en) | Process for preparing formulations of lipid-regulating drugs | |
JPH08291063A (ja) | 易吸収性製剤及びその製造法 | |
WO2009034409A2 (fr) | Compositions pharmaceutiques de rheine ou de diacereine | |
KR100981751B1 (ko) | 프란루카스트를 함유하는 과립 및 그의 제조방법 | |
JPH05139973A (ja) | ニフエジピン含有固形製剤の製造方法 | |
US20220241230A1 (en) | Diclofenac sachet composition | |
JP2813792B2 (ja) | マレイン酸イルソグラジン経口投与用製剤およびその製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |